Research at the Lady Davis Institute

The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.

Dr. Pierre Pluye, a Senior Investigator in the Centre for Clinical Epidemiology and Community Studies at the Lady Davis Institute, has been named 2017 Family Medicine Researcher of the Year by the College of Family Physicians of Canada.

In the most recent round of funding by the Canadian Institutes of Health Research, Dr. Stéphane Richard received a CIHR Foundation Grant worth $3.5 million over seven years.

Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH, is being honoured with the 2017 Distinguished Scientist Award by the Canadian Society for Clinical Investigation.

In the ongoing fight against dementia, a research team in the Lady Davis Institute, is looking at electro-magnetic stimulation as a method of targeting the illness through the brain’s electrical impulses.

Research by Dr. Jonathan Afilalo has revealed that frailty is a major risk factor for death and disability after two types of cardiac surgical procedures.

The Canadian Task Force on Preventive Health Care has recommended against screening for chronic hepatitis C virus (HCV) in adults who are at low risk.

Although there is little scientific evidence that behaviour can be changed with the help of neurofeedback, some benefits may still result from the technique’s placebo effects.

Canadian men—regardless of their age, education or income level—generally lack knowledge about the risk factors that contribute to male infertility, the first large-scale study of its kind has revealed.

A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.